Fig. 4From: Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validationMolecular docking of ligands and target proteins. A Docking process of osthole, co-crystal ligand with HSP90AA1 protein. B Docking process of osthole, co-crystal ligand with PI3KR1 protein. C Docking process of osthole, co-crystal ligand with SRC protein. D Heatmap of binding energy between ligands and target proteinsBack to article page